Nova Eye Medical Limited
ELXMF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $40,285 | $37,078 | $32,580 | $28,731 |
| - Cash | $5,055 | $2,258 | $6,151 | $2,612 |
| + Debt | $3,017 | $3,376 | $3,349 | $1,215 |
| Enterprise Value | $38,247 | $38,196 | $29,778 | $27,334 |
| Revenue | $16,342 | $12,925 | $13,186 | $10,139 |
| % Growth | 26.4% | -2% | 30.1% | – |
| Gross Profit | $10,333 | $8,555 | $11,260 | $1,322 |
| % Margin | 63.2% | 66.2% | 85.4% | 13% |
| EBITDA | -$1,539 | -$5,184 | -$1,540 | -$4,184 |
| % Margin | -9.4% | -40.1% | -11.7% | -41.3% |
| Net Income | -$3,665 | -$5,394 | -$3,165 | -$5,625 |
| % Margin | -22.4% | -41.7% | -24% | -55.5% |
| EPS Diluted | -0.014 | -0.024 | -0.015 | -0.029 |
| % Growth | 41.3% | -62.1% | 49.5% | – |
| Operating Cash Flow | -$2,573 | -$3,577 | -$3,738 | -$4,119 |
| Capital Expenditures | -$205 | -$93 | -$17 | -$354 |
| Free Cash Flow | -$2,778 | -$3,670 | -$3,755 | -$4,473 |